On this page
What each program costs in Tennessee
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 15 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 16 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 17 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 18 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the Tennessee State Group Insurance Program (Partners for Health) cover GLP-1s for weight loss?
Tennessee's state group insurance covers certain anti-obesity medications through CVS Caremark with prior authorization. Members pay 25% coinsurance for weight-loss medications on every plan in 2026.
Tennessee Benefits Administration (Partners for Health)
Partners for Health says certain anti-obesity medications are covered with prior authorization.
“Certain anti-obesity medications are covered with a prior authorization which may be requested by your provider.”
https://www.tn.gov/partnersforhealth/your-life--your-benefits/weight-management.html · read Oct 29, 2026
Tennessee Benefits Administration (Partners for Health)
The 2026 guide sets 25% coinsurance for weight-loss medications.
“Members will pay 25% coinsurance for medications prescribed for weight loss for all plans.”
https://www.tn.gov/content/dam/tn/partnersforhealth/documents/2026_new_hire_guide_lg.pdf · read Oct 29, 2026
Does Tennessee Medicaid (TennCare) cover GLP-1s for weight loss?
Covered, with conditions
TennCare's November 2, 2026 criteria cover Wegovy and Zepbound for the management of obesity with prior authorization and BMI rules. Read from state documents Nov 6, 2026.
What Tennessee Medicaid (TennCare)'s documents say about each drug for weight loss. Read Nov 6, 2026. Tennessee Division of TennCare, with Optum Rx as pharmacy vendor.
WegovyYes
Prior authorization. Age 12 or older. Adults need BMI above 30, or above 27 with a weight-related condition; under 18 need BMI at or above the 95th percentile. Prescriber attests to nutrition and lifestyle changes. Renewal has its own criteria. Also has paths for heart risk and MASH.
“Wegovy® Injection Initial PA Criteria: • Patient must be the labeled age minimum (Wegovy ≥ 12) ; AND • Treatment is for the management of obesity;”
TennCare PDL Clinical Criteria, Step Therapy, and Quantity Limits (Optum Rx) · Effective Nov 2, 2026 · read Nov 6, 2026
ZepboundYes
Prior authorization. Age 18 or older. BMI above 30, or above 27 with a weight-related condition. Prescriber attests to nutrition and lifestyle changes. Renewal has its own criteria. Also has a path for sleep apnea.
“Zepbound® single dose prefilled pen Initial PA Criteria: • Patient must be the labeled age minimum (Zepbound ≥ 18) ; AND • Treatment is for the management of obesity;”
TennCare PDL Clinical Criteria, Step Therapy, and Quantity Limits (Optum Rx) · Effective Nov 2, 2026 · read Nov 6, 2026
OzempicNo
The criteria require a confirmed type 2 diabetes diagnosis, with prior authorization.
“Type 2 Diabetes: Ozempic® injection Initial PA Criteria: • Submission of medical records (e.g. chart notes) confirming diagnosis of type 2 diabetes”
TennCare PDL Clinical Criteria, Step Therapy, and Quantity Limits (Optum Rx) · Effective Nov 2, 2026 · read Nov 6, 2026
MounjaroNo
The criteria require a confirmed type 2 diabetes diagnosis, with prior authorization.
“Type 2 Diabetes: Mounjaro® PA Criteria: • Submission of medical records (e.g. chart notes) confirming diagnosis of type 2 diabetes”
TennCare PDL Clinical Criteria, Step Therapy, and Quantity Limits (Optum Rx) · Effective Nov 2, 2026 · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Tennessee Division of TennCare, with Optum Rx as pharmacy vendor documents. KFF's January 2026 map listed this program as covered; the documents we read agree.
- Aug 1, 2025 · Policy changeBegan covering medications for obesity management for adults and children per label, under interim prior authorization criteria.
“Effective August 1, 2025, medications for obesity management will be covered for both adults (ages 21 and over) and children per medication label”
Tennessee Division of TennCare provider notice · Effective Aug 1, 2025 · read Nov 6, 2026
Weight loss
Covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
40,724 prescriptions
Ozempic and Mounjaro, 2025
88,690 prescriptions
Neighbours covering weight loss
4 of 8
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Tennessee Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Tennessee Medicaid as "covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Tennessee Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Tennessee Medicaid pay for?
135,961 GLP-1 prescriptions in 2025, 20th of the 50 states and DC, with $142.7 million reimbursed before rebates. Counting the share other payers covered, $144.1 million.
Prescriptions, 2025
135,961
20th of 51
Medicaid paid
$142.7M
19th of 51, before rebates
Per prescription
$1,050
$1,051 nationally
Weight-loss brands
30%
13th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Tennessee is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 30% of Tennessee Medicaid's GLP-1 prescriptions in 2025 (40,724). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was Tennessee Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 58,150 | 43% | $56.0 million | $964 |
| Mounjaro | 30,540 | 22% | $31.7 million | $1,037 |
| Wegovyapproved for weight management | 26,236 | 19% | $34.3 million | $1,308 |
| Zepboundapproved for weight management | 14,030 | 10% | $14.8 million | $1,056 |
| Trulicity | 2,481 | 1.8% | $2.3 million | $936 |
| Rybelsus | 1,943 | 1.4% | $1.9 million | $963 |
| Liraglutide (generic) | 1,605 | 1.2% | $792,855 | $494 |
| Saxendaapproved for weight management | 458 | 0.3% | $504,828 | $1,102 |
| Victoza | 273 | 0.2% | $175,039 | $641 |
| Bydureon | 245 | 0.2% | $196,938 | $804 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in Tennessee?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 4 in Tennessee. The register does not say which, if any, supplies a program on this page.
- NLRx, LLC, Cookeville. Registered since Aug 7, 2026; not yet inspected by FDA.
- Simple RX Solutions, P.C., Lewisburg. Registered since Aug 26, 2026; not yet inspected by FDA.
- University of Tennessee, Memphis. Registered since May 19, 2024; not yet inspected by FDA.
- Wells Pharmacy, Inc., Dyersburg. Registered since Jun 7, 2016; last FDA inspection Apr 9, 2026.
On Medicare in Tennessee?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Tennessee and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
4 of the 8 states next to Tennessee cover GLP-1s for weight loss through Medicaid: Mississippi, Missouri, North Carolina and Virginia. None has a lower cash floor than Tennessee's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Tennessee | Covered | 18 | $39/mo |
| Alabama | Not covered | 15 | $39/moWellmedr |
| Arkansas | Not covered | 16 | $39/moWellmedr |
| Georgia | Not covered | 18 | $39/moWellmedr |
| Kentucky | Not covered | 19 | $39/moWellmedr |
| Mississippi | Covered | 15 | $39/moWellmedr |
| Missouri | Zepbound only | 18 | $39/moWellmedr |
| North Carolina | Covered | 19 | $39/moWellmedr |
| Virginia | Covered | 19 | $39/moWellmedr |





















